Inhibitory effect of CC chemokine ligand 23 (CCL23)/ transcription factor activating enhancer binding protein 4 (TFAP4) on cell proliferation, invasion and angiogenesis in hepatocellular carcinoma

Abstract

Hepatocellular carcinoma (HCC) is a highly vascularized solid tumor with a fast growth rate. According to bioinformatics analysis, CC chemokine ligand 23 (CCL23) has clinical significance for survival and prognosis in HCC. The online databases TCGA and CCLE were used to analyze the expression level of CCL23, and its expression was also measured in HCC cell lines by RT-qPCR and Western blotting. The STRING database and co-immunoprecipitation were employed to evaluate the association between CCL23 and transcription factor activating enhancer binding protein 4 (TFAP4). Overexpression plasmids for CCL23 (Ov-CCL23) and TFAP4 (Ov-TFAP4) were transfected into Huh-7 cells to detect TFAP4 expression. Huh-7 cells injected with OV-negative control (NC)/Ov-CCL23 or OV-NC/Ov-CCL23 plus Ov-TFAP4 were utilized to study the function of CCL23/TFAP4. Cell proliferation, invasion and human umbilical vein endothelial cell tube formation assays were conducted. The database revealed decreased expression of CCL23 in HCC and that it was commonly downregulated in HCC cell lines. TFAP4 expression was negatively correlated with CCL23. The overexpression of CCL23 inhibited the proliferation and invasion of Huh-7 cells, whereas TFAP4 blocked these effects. Similarly, the supernatant of CCL23-upregulated cells exhibited significantly lower tube formation potential, and low vascular endothelial growth factor A (VEGFA), VEGFRs expression compared with those of non-transfected Huh-7 cells, while TFAP4 plasmid co-transfected markedly increased these. Taken together, the present study suggests that CCL23 is expressed at low levels in HCC; it inhibits HCC cell proliferation, invasion and angiogenesis in vitro ; and its action is negatively associated with and can be blocked by TFAP4.

Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma

“…Therefore, overcoming hypoxia is a significant strategy for the treatment of HCC [ 56 ]. A growing body of evidence suggests that inhibition of cell proliferation is a significant means to treat HCC and beneficial for improving patient survival [ 57 ]. Similarly, the CC terms (e.g., cellular response to drug) also exerts an important effect in the pathogenesis of HCC.…”

ZNF251 is a novel prognostic biomarker and correlated with the immunosuppressive microenvironment in hepatocellular carcinoma

“…The loss of CCL23 facilitated the progression of liver cancer by coordinating immune evasion [40]. Furthermore, CCL23 was recently reported to directly inhibit HCC cell proliferation, invasion, and angiogenesis in vitro [41].…”

MiR-4739 inhibits the malignant behavior of esophageal squamous cell carcinoma cells via the homeobox C10/vascular endothelial growth factor A/phosphatidylinositol 3-kinase/AKT pathway

“…One of the hallmarks of cancer is sustained angiogenesis [ 47 ]. Vascular endothelial growth factors, especially VEGFA, play important roles in tumor angiogenesis [ 34 , 48 , 49 ]. In addition, it has been reported that HOXC10 promotes tumor angiogenesis and induces VEGFA expression in glioblastoma by binding to protein arginine methyltransferase-5.…”

“…To evaluate angiogenesis in vitro , 200 μL culture medium containing 10% fetal bovine serum was added to each well of a 24-well plate that was previously coated with 300 μL of Matrigel per well (BD Biosciences, Franklin Lakes, NJ, USA) [ 34 ]. In each Transwell chamber, we plated approximately 5 × 10 4 human umbilical vein endothelial cells that were cocultured with ESCC cells previously transfected with miR-4739 mimics or scramble.…”